BioSpring
La Jolla, CA, United States biospring.net
From their website, Nov 2026
Work here? Claim this listing
- GMP
About
BioSpring develops and manufactures therapeutic and diagnostic nucleic acids, including oligonucleotides and mRNA, for pharmaceutical, biotech, and academic customers. It supports programs from research and preclinical stages through clinical and commercial supply, with sites in Frankfurt, Germany, and additional locations in the USA and Japan.
Services
GMP oligonucleotide manufacturing
Manufactures therapeutic oligonucleotides from early development through commercial supply, including cGMP and pre-GMP grades.
Oligonucleotide analytical services
Provides analytical support for drug substance and drug product, including release, stability, characterization, and method work.
Bioanalytical services
Extracts and quantifies oligonucleotides in biological samples and supports metabolite profiling, bioanalysis, and toxicity studies.
Project management
Provides project managers to coordinate planning, reporting, timelines, and cross-functional communication for therapeutic oligonucleotide and mRNA programs.
Process development
Develops scalable and reproducible manufacturing processes for oligonucleotide and mRNA programs, including risk evaluation, optimization, and scale-up.
Regulatory support
Supports CMC regulatory filings, dossier sections, scientific advice preparation, risk assessments, and post-approval lifecycle management.
Conjugated oligonucleotide manufacturing
Manufactures oligonucleotide conjugates and supports conjugation, purification, analytical development, and related documentation.
XNA-modified oligonucleotide manufacturing
Provides XNA amidites and manufactures XNA-modified oligonucleotides for R&D and development purposes.
Antisense oligonucleotide manufacturing
Manufactures ASOs, including gapmers, for therapeutic applications.
CpG ODN manufacturing
Manufactures CpG oligodeoxynucleotides, including CpG 7909, for immune stimulation and related applications.
Clinical GMP manufacturing
Produces oligonucleotides for clinical supply across Phases I to III under cGMP conditions.
Pre-GMP manufacturing
Provides customizable pre-GMP nucleic acid manufacturing for programs that do not yet require full cGMP compliance.
Preclinical manufacturing
Provides manufacturing for preclinical studies, including toxicology studies and preclinical animal testing.
Research-grade manufacturing
Provides manufacturing for early-stage research and discovery projects.
Diagnostic-grade manufacturing
Provides manufacturing for diagnostic applications.
Characterization services
Characterizes nucleic acid products using LC-MS, LC-MS/MS, NGS, spectroscopic, and chromatographic methods.
Method development and transfer
Develops and transfers analytical methods for nucleic acid drug substance and drug product.
Method validation
Validates analytical methods for nucleic acid programs, including ICH-compliant work where applicable.
Release and stability testing
Performs release testing and stability studies for drug substance and drug product.
- Turnaround
- Immediate onboarding
- What to send
- Molecule type, sequence, development stage, and target scale · Biofluids · Tissues
- Minimums and prices
- CpG 7909 available; pricing not stated
Capabilities
As they state on their website or in their listing.
- Assays and studies
- Oligonucleotides · Process development · mRNA · Stability studies · Bioanalysis · LC-MS/MS · qPCR · hELISA · LC · LC-MS · NGS · Activity assays
12 more
Impurity profiling · Release testing · Reference standard characterization · In-process control analysis · Method development · Method validation · Method transfer · Stability testing · Stress studies · Raw material testing · Impurity analysis · Reference standard qualification - Scale and capacity
- Grams to tens of kilograms · Mg to multi-kg scale · Hundreds of milligrams to 50 grams · µg to multi-grams · Multi-kilogram manufacturing process · Seven cGMP manufacturing cleanrooms · Three independent cGMP cleanrooms · Nine analytical laboratories · Small batch sizes for ultrarare and rare disease programs · Multi-kg batch sizes · ~100 kg larger batch sizes · Multi-ton facility
- Therapeutic areas
- Genetic disorders · Cancer · Infectious diseases · Viral infections · Autoimmune diseases · Neurological disorders · Ultrarare disease · Rare disease
- Scales
- Milligram · Gram · Kilogram
- Data supplied
- LC-MS
Instruments and platforms
- LC-MS
- LC-MS/MS
- NGS
Modalities and species
- Modalities
- Small molecule · Antibody · Peptide · Oligonucleotide · mRNA
- Species and models
- Human · Animal tissue samples · Biofluids · Plasma · Serum · Blood · Urine · CSF · Sputum · Nasal fluid · Brain · Heart
4 more
Liver · Spleen · Muscle · Tissues
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing
Company
- Type
- CRDMO
- Founded
- 1997
Locations
- Address
- 888 Prospect Street, Suite 200 La Jolla, CA 92037 USA
- Sites
- Frankfurt am Main, Germany · Tokyo, Japan
- Serves
- worldwide, US, EU, UK, Japan, Brazil, Saudi Arabia, China, global
Similar labs
Work here? Claim this listing